OrthAlign Inc. has announced the FDA clearance of its Lantern handheld hip arthroplasty technology, designed to enhance positioning for direct anterior hip arthroplasty procedures. The device includes accelerometers and gyroscopes to improve navigation during total hip arthroplasty in the supine position. This new addition to the Lantern platform expands the company’s capabilities and commitment to innovation in joint replacement surgery. CEO Eric Timko emphasizes the importance of delivering efficient and technologically advanced solutions for total joint replacement. The Lantern platform, which already includes applications for knee arthroplasties, now offers surgeons an easy and confident way to incorporate technology into total hip replacements.
Source link
OrthAlign receives FDA 510(k) clearance for handheld THA application
